Home > PS Ratio > PANACEA BIOTEC

PANACEA BIOTEC
PS (Price/Sales) Ratio

The Current P/S Ratio of PANACEA BIOTEC is 5.61.

Share Price ₹515.1May 12,2025
Market Cap ₹3,157.6 Cr
Sales-TTM₹563.0 CrTTM-Consolidated Results
Price/Sales5.61xCalculated as Market Cap/Sales
Explore Stock Analytics
COMMUNITY POLL
for PANACEA BIOTEC
Please provide your vote to see the results
PANACEA BIOTEC is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks

Definition & Calculation of PS (Price/Sales) ratio of PANACEA BIOTEC

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of PANACEA BIOTEC is calculated as :

Current Market Cap [ ₹3,157.6 Cr] as on May 12,2025

(/) Sales [ ₹563.0 Cr] based on TTM-Consolidated Results

(=) P/S Ratio [ 5.61x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for PANACEA BIOTEC , the investors are currently willing to pay '5.61 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of PANACEA BIOTEC !

The chart below summarizes the trend in P/S Ratio of PANACEA BIOTEC over the last five years.

Historical PS (Price/Sales) ratio chart of PANACEA BIOTEC


PS Ratio Performance Analysis for PANACEA BIOTEC

- PANACEA BIOTEC 's latest p/e ratio is 5.61x.

- PANACEA BIOTEC 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 1.42x.

- PANACEA BIOTEC 's operated at median p/e ratio of 1.37x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, PANACEA BIOTEC 's p/e ratio peaked in Mar2021 at 1.74x.

- PANACEA BIOTEC 's p/e ratio hit its five-year low in Mar2020 of 1.23x.


How does PANACEA BIOTEC 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Sales (Cr)PS RatioMarket Cap (Cr)
PANACEA BIOTEC 563.05.613,157.6
SUN PHARMACEUTICAL INDUSTRIES LTD51,602.57.84404,588.0
DIVIS LABORATORIES LTD9,078.017.37157,711.0
CIPLA LTD26,981.24.53122,115.0
TORRENT PHARMACEUTICALS LTD11,302.09.70109,589.0
DR REDDYS LABORATORIES LTD32,643.93.0699,746.6
MANKIND PHARMA LTD11,641.08.85103,054.0
ZYDUS LIFESCIENCES LTD22,247.44.0089,016.5
LUPIN LTD22,001.64.2493,193.1
AUROBINDO PHARMA LTD30,921.82.2770,044.7
ABBOTT INDIA LTD6,243.210.2363,839.2

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs PANACEA BIOTEC 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 2.27x
Max industry PS 17.37x
Median industry PS 5.61x
Average industry PS 7.06x



You may also like the below Video Courses